|
Effects | Extract/compound dose | Animal/cell line | Study design | Control | Mechanism/results | Ref |
|
Anti-inflammatory effect | 1.5 g/kg (40%, 60%, 80%) ethanol extract solution | Xylene-induced mice ears edema | In vivo | Aspirin | By inhibiting the activity of NAAA, intracellular biological activity was increased and the level of proinflammatory factors was decreased. | [93] |
Egg white-induced mice pettitoes swelling |
Tampon granulation-induced mice swelling |
0.4 mL 50% ethanol extract solution | Xylene-induced mice ears edema | In vivo | Aspirin | It plays an anti-inflammatory role by reducing the levels of inflammatory factors such as MDA and TNF-α. | [92] |
Carrageenan-induced mice swelling |
0.15 and 0.29 g/kg volatile oil of AP | Egg white-induced rat pettitoes swelling | In vivo | Hexadecadrol | It plays an anti-inflammatory role by inhibiting the release of inflammatory factors such as 5-HT. | [94] |
AP 95% ethanol extract solution (0.1 g/L, 1 g/L, 10 g/L) | LPS-induced rat peritoneal macrophages | In vitro | Celecoxib | AP inhibited COX-1 and COX-2 in varying degrees, and there was a dose-response relationship. | [99] |
Indomethacin |
DMSO |
Volatile oil of AP (10 mg/L, 50 mg/L, 250 mg/L) | LPS-induced RAW 264.7 cell | In vitro | None | By inhibiting the hydrolysis activity of NAAA and increase the level of N-PEA, downregulating the expression of TNF-α, iNOS, IL-6 mRNA, and inhibiting the release of TNF-α and NO. | [100] |
Angesesquid A and angesesquid B | Primary chondrocytes of rat intervertebral disc | In vitro | None | Inflammation is inhibited by inhibiting the release of NO. | [101] |
Analgesic | 1.5 g/kg (40%, 60%, 80%) ethanol extract solution | Acetic acid-induced and tail-immersion-induced writhing | In vivo | Aspirin | By inhibiting the activity of NAAA, the intracellular biological activity was increased and the level of inflammatory factors was reduced to play an analgesic role. | [93] |
0.4 mL 50% ethanol extract solution | Hot plate, acetic acid, and formalin-induced pain | In vivo | Aspirin | By inhibiting the level of MDA and inflammatory factors was reduced to play an analgesic role. | [92] |
0.15 and 0.29 g/kg volatile oil of AP | Hot plate, acetic acid -induced mice pain | In vivo | Aspirin | AP has an analgesic effect similar to that of nSAID rather than narcotic analgesics. | [94] |
Morphine hydrochloride |
Coumarins in AP | Spared nerve injury model rat | In vivo | Morphine | AP has the analgesic effect mainly related to reducing the concentration of proinflammatory cytokines of TNF-α, IL-1 β, and IL-6 and reducing the expression of TRPV1 and perk in the damaged neurons. | [94] |
Cardiovascular effect | 0.4 g/kg, 1.0 g/kg AP ethanol extract | ADP-induced mice platelet aggregation | In vivo | Black | AP alcohol extract can shorten the thrombus length and prolong the tail hemorrhage time of mice to inhibit ADP-induced platelet aggregation in mice. | [103] |
10 mg/kg GABA | Multiple arrhythmia models | In vivo | Black | GABA could prolong the start time, reduce the incidence of ventricular tachycardia, shorten the duration of ventricular tachycardia, reduce the mortality of ventricular fibrillation, reduce APA and APO50 and APO90. | [104] |
AP ethanol extract | Patients with vertigo | In vivo | Compound Danshen | By reducing the whole blood viscosity, plasma viscosity and red blood cell aggregation index of vertigo patients, increasing the cerebral blood flow speed to play the role of promoting blood circulation and removing stasis. | [105] |
1.28 g/ml AP 95% ethanol extract | Thoracic aortic rings in rats | In vitro | CaCl2 | AP had a good diastolic effect on vasoconstriction caused by PE and KCl, and its mechanism was related to the influx of CaCl2. | [106] |
3.75–30 μg/ml AP 95% ethanol extract and osthol | Human umbilical vein endothelial cells | In vitro | None | Inhibition of angiogenesis by stagnation of endothelial cycle mainly in G0-G1. | [11] |
Human colon cancer cell |
Neuroprotective effect | AP 90% ethanol extract (2.7 g/kg/d, 8.1 g/kg/d, 24.3 g/kg/d) | D-Galactose-induced mice aging model | In vivo | Model | AP’s delay of brain aging is associated with anti-free radical peroxide damage, reduction of immunosuppression of arachidonic acid metabolites, and antagonism of brain inflammation. | [95] |
12 ml/kg/d AP alcohol extract or AP water extract | Aged mice | In vivo | Black | AP could reduce the content of MDA content and the deletion of DNA fragment in natural aging mice. | [96] |
Coumarin in AP with 22.05 mg/kg/d, 66.15 mg/kg/d, 198.45 mg/kg/d | Lactacystin-induced PD rat model | In vivo | Madopar, ibuprofen | Inhibition of lipid peroxidation in serum and brain tissue, increase of antioxidant enzyme activity, and decrease of excitatory amino acid Glu content in serum and brain tissue. | [107] |
Coumarin in AP with 3 g/kg/d | Lactacystin-induced PD rat model | In vivo | Madopar, celecoxib | Coumarin in AP and AP may protect PD by inhibiting endoplasmic reticulum stress. | [108] |
AP granules 3 g/kg/d |
Compound AP granules 6.3 g/kg/d |
AP 90% ethanol extract or water extract (18 g/kg/d) | Mice aged 16 months | In vivo | Water | It can improve the activity of mitochondrial respiratory chain enzyme complex I and IV in the brain of aged mice and protect the oxidative damage of mitochondrial DNA in mice. | [109] |
2 ml/mouse AP extract | Aβ-induced rat dementia model | In vivo | Indometacin | AP can inhibit the expression of P38 MAPK in rat brain and improve the learning and memory ability of dementia model rats. | [110] |
1 g/kg or 4 g/kg AP ethanol extract | D-Galactose or sodium nitrite-induced Alzheimer’s disease mice | In vivo | Water | AP can delay the occurrence of Alzheimer’s disease by increasing SOD and reducing AChE in brain tissue. | [111] |
20 mg/ml osthol | APP/PS1 double transgenic mice | In vivo | None | Osthol can promote the survival of NT-3-BM-NSCs and enhance the cholinergic nerve function in the brain. | [112] |
10–250 mg/ml coumarin in AP | Aβ-induced mice nerve injury model | In vivo | None | By promoting the expression of CREB and BDNF, the expression of P-CREB and BDNF is increased to play a neuroprotective role. | [113] |
9, 18, 36 ng/kg AP extract | MOG35-55 peptide fragment-induced mice EVE model | In vivo | Prednisone acetate | It can alleviate demyelination injury, inhibit the secretion of proinflammatory cytokines by spleen lymphocytes, and has neuroprotective effect. | [114] |
Antibacterial effect | AP petroleum ether extract | Fungus | In vitro | None | AP essential oil has different degree of bacteriostatic effect on different fungi. | [115] |
1 g/L AP ethanol extract | Penicillium italicum | In vitro | None | Isobergamolactone, sphondin, pimpinellin, and isopimpinellin in AP showed antibacterial activity. | [116] |
Penicillium digitatum |
Colletotrichum gloeosporioides |
Antioxidation effects | 12 ml/kg/d AP alcohol extract or AP water extract | Aged mice | In vivo | Black | AP could reduce the level of MDA in the brain tissues of mice. | [96] |
1 g/kg or 4 g/kg AP ethanol extract | D-Galactose or sodium nitrite-induced Alzheimer’s disease mice | In vivo | Water | AP could delay the occurrence of Alzheimer’s disease by increasing the level of SOD. | [111] |
0.4 ml AP 50% ethanol extract | Carrageenan-induced mice swelling | In vivo | Aspirin | AP alcohol extract could inhibit the concentration of MDA with the inhibitory rate of 23.49%. | [92] |
Antitumor effect | 0.3125–10 mg/ml AP aqueous solution | HMVECs | In vitro | Cyclophosphamide | AP can inhibit the proliferation of human microvascular endothelial cells. Inhibition of angiogenesis. | [97] |
SMMC-7721 |
Antigastric ulcer | Chloroform, petroleum ether, and ethyl acetate extracts of AP | Aspirin-ethanol solution-induced mice gastric ulcer model | In vivo | Cimetidine | The fat-soluble part of AP is the effective part against gastric ulcer. | [98] |
|